subfoveal

subfoveal

(sŭb-fō′vē-ăl) [″ + ″]
Beneath the fovea of the eye, that is, beneath the central portion of the macula.
References in periodicals archive ?
The subfoveal CT was significantly lower in the high myopia group (mean, 218.
All patients and controls underwent EDI-OCT to measure subfoveal choroidal thickness (SFCT), inner and outer diameters as well as arterial and venous wall thickness, and arterial venous ratio of the inner (AVR[sub]in) and outer diameters (AVR[sub]out).
It is not only helpful in detecting DME early, but has the added advantage of being able to reveal not only the presence of cystoid macular oedema, but subfoveal serous retinal detachment, vitreomacular traction or an epiretinal membrane which cannot be detected in FFA.
studied subfoveal choroidal thickness (SFCT) in healthy subjects and measured SFCT every 3 hours over a 24-hour period [4].
The NT-503 ECT has been developed for the treatment of recurrent subfoveal choroidal neovascularization secondary to age related macular degeneration (wet AMD).
The subfoveal, temporal, and nasal fovea choroidal thicknesses (CTs) were measured by using spectral-domain OCT (Spectralis, wavelength: 870 nm) with EDI modality.
The trial is designed to assess the safety and tolerability of topical ocular PAN-90806 at three dosage strengths in patients with active, subfoveal choroidal neovascularization associated with neovascular AMD.
On fluorescein angiography, a peripapillary subretinal neovascular membrane with associated subfoveal hemorrhage was observed (Figure 1).
Liposomal amphotericin B was substituted for prophylactic anidulafungin, and an intravitreal injection of amphotericin B was given for a subfoveal lesion.
The short-term safety study applied 24 Gy single-fraction beta brachytherapy to the subfoveal neovascular membrane of the eye to treat wet AMD.
Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration: Two-Year Results of a Randomized Clinical Trial Including Lesions with Occult with No Classic Choroidal Neovascularization-Verteporfin in Photodynamic Therapy Report 2.